Implementation of Therapeutic and/or Abuse Drug Analysis in Blood Samples via Chemiluminescent Immunoassay Technique using the Randox Evidence Investigator™ Equipment

Article Fingerprint
Research ID 353HE

IntelliPaper

Abstract

The Toxicology Laboratory of the Instituto Nacional de Ciencias Forenses de Guatemala -INACIF- is responsible for analysing the biological signs in the search for chemical substances, among which drugs are found. Because Laboratories constantly need to update their technology, it was necessary to implement a new chemiluminescence immunoassay technique using the Randox Evidence Investigator TM kit. This technique is useful as it provides accurate and reproducible results. To implement this technique, 10 blood samples with a positive result for drugs habitually detected in the Toxicology Laboratory and 10 blood samples with a negative result for drugs were analysed, said analysis gave as a result the fulfilment of what was expected for positive and negative drugs. The time invested in analysis was also evaluated, which was approximately 4 to 4.5 hours.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

Not applicable

Data Availability

The datasets used in this study are openly available at [repository link] and the source code is available on GitHub at [GitHub link].

Funding

This work did not receive any external funding.

Cite this article

Generating citation...

Related Research

  • Classification

    LCC Code: RA1215

  • Version of record

    v1.0

  • Issue date

    19 November 2024

  • Language

    English

Article Placeholder
Open Access
Research Article
CC-BY-NC 4.0
Support